ASX - By Stock
|
OSX |
Re:
Ann: A$18.7m Osteopore, NDCS and A*STAR project hits milestones
|
|
Mom88
|
67 |
16K |
1 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
67
|
16K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
News: OSX Osteopore Raises A$2.9M From Entitlement Offer
|
|
Mom88
|
95 |
28K |
2 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
95
|
28K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Annual Report to Shareholders
|
|
Mom88
|
14 |
4.7K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
14
|
4.7K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Reinstatement to Official Quotation
|
|
Mom88
|
18 |
6.1K |
4 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
18
|
6.1K
|
4
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
Mom88
|
15 |
5.6K |
1 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
15
|
5.6K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
Mom88
|
15 |
5.6K |
2 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
15
|
5.6K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
Mom88
|
63 |
26K |
1 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
63
|
26K
|
1
|
|
ASX - By Stock
|
BB1 |
Re:
The float
|
|
Mom88
|
91 |
45K |
1 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
91
|
45K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
Mom88
|
63 |
26K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
63
|
26K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
Mom88
|
63 |
26K |
3 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
63
|
26K
|
3
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
Mom88
|
63 |
26K |
6 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
63
|
26K
|
6
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Mom88
|
45 |
17K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
45
|
17K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Mom88
|
45 |
17K |
0 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
45
|
17K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Mom88
|
45 |
17K |
3 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
45
|
17K
|
3
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Mom88
|
45 |
17K |
5 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
45
|
17K
|
5
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Mom88
|
45 |
17K |
3 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
45
|
17K
|
3
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Mom88
|
45 |
17K |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
45
|
17K
|
3
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Investor Presentation
|
|
Mom88
|
4 |
1.5K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
4
|
1.5K
|
0
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Gronnedal REE Project Maiden Inferred Resource Declared
|
|
Mom88
|
48 |
12K |
0 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
48
|
12K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Appendix 4E Preliminary Final Report
|
|
Mom88
|
2 |
884 |
0 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
2
|
884
|
0
|
|
ASX - By Stock
|
OSX |
Re:
News: OSX Osteopore Says Shareholders Approved Consolidation Of Capital
|
|
Mom88
|
7 |
2.3K |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
7
|
2.3K
|
1
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Gronnedal REE Project Maiden Inferred Resource Declared
|
|
Mom88
|
48 |
12K |
1 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
48
|
12K
|
1
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Gronnedal REE Project Maiden Inferred Resource Declared
|
|
Mom88
|
48 |
12K |
3 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
48
|
12K
|
3
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Gronnedal REE Project Maiden Inferred Resource Declared
|
|
Mom88
|
48 |
12K |
0 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
48
|
12K
|
0
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Gronnedal REE Project Maiden Inferred Resource Declared
|
|
Mom88
|
48 |
12K |
0 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
48
|
12K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial
|
|
Mom88
|
73 |
25K |
3 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
73
|
25K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial
|
|
Mom88
|
73 |
25K |
3 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
73
|
25K
|
3
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Mom88
|
7 |
2.6K |
0 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
7
|
2.6K
|
0
|
|
ASX - By Stock
|
AUE |
Re:
Ann: Results of Meeting
|
|
Mom88
|
3 |
1.3K |
1 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
3
|
1.3K
|
1
|
|
Charts
|
AB1 |
Re:
Recent Animoca Investments - Amazing!
|
|
Mom88
|
281 |
124K |
9 |
02/11/23 |
02/11/23 |
Charts
|
281
|
124K
|
9
|
|
Charts
|
AB1 |
Re:
Recent Animoca Investments - Amazing!
|
|
Mom88
|
281 |
124K |
5 |
31/10/23 |
31/10/23 |
Charts
|
281
|
124K
|
5
|
|
Charts
|
AB1 |
Re:
Recent Animoca Investments - Amazing!
|
|
Mom88
|
281 |
124K |
3 |
31/10/23 |
31/10/23 |
Charts
|
281
|
124K
|
3
|
|
Charts
|
AB1 |
Re:
Recent Animoca Investments - Amazing!
|
|
Mom88
|
281 |
124K |
5 |
31/10/23 |
31/10/23 |
Charts
|
281
|
124K
|
5
|
|
ASX - By Stock
|
3MF |
Re:
Ann: Suspension from Official Quotation
|
|
Mom88
|
30 |
9.1K |
1 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
30
|
9.1K
|
1
|
|
ASX - By Stock
|
3MF |
Re:
Ann: Suspension from Official Quotation
|
|
Mom88
|
30 |
9.1K |
2 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
30
|
9.1K
|
2
|
|
ASX - By Stock
|
3MF |
Re:
Ann: Suspension from Official Quotation
|
|
Mom88
|
30 |
9.1K |
1 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
30
|
9.1K
|
1
|
|
ASX - By Stock
|
3MF |
Re:
Ann: Suspension from Official Quotation
|
|
Mom88
|
30 |
9.1K |
2 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
30
|
9.1K
|
2
|
|
ASX - By Stock
|
3MF |
Re:
Peers
|
|
Mom88
|
21 |
3.4K |
1 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
21
|
3.4K
|
1
|
|
ASX - By Stock
|
3MF |
Re:
Peers
|
|
Mom88
|
21 |
3.4K |
1 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
21
|
3.4K
|
1
|
|
ASX - By Stock
|
CI1 |
Re:
Ann: Preliminary Final Report
|
|
Mom88
|
35 |
6.5K |
1 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
35
|
6.5K
|
1
|
|
ASX - By Stock
|
3MF |
Re:
Peers
|
|
Mom88
|
21 |
3.4K |
1 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
21
|
3.4K
|
1
|
|
ASX - By Stock
|
CI1 |
Re:
Ann: Preliminary Final Report
|
|
Mom88
|
35 |
6.5K |
4 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
35
|
6.5K
|
4
|
|
ASX - By Stock
|
CI1 |
Re:
Ann: Preliminary Final Report
|
|
Mom88
|
35 |
6.5K |
1 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
35
|
6.5K
|
1
|
|
ASX - By Stock
|
3MF |
Re:
Peers
|
|
Mom88
|
21 |
3.4K |
2 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
21
|
3.4K
|
2
|
|
ASX - By Stock
|
3MF |
Re:
Peers
|
|
Mom88
|
21 |
3.4K |
1 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
21
|
3.4K
|
1
|
|
ASX - By Stock
|
CI1 |
Re:
CI1 General discussion
|
|
Mom88
|
4.6K |
725K |
2 |
27/08/22 |
27/08/22 |
ASX - By Stock
|
4.6K
|
725K
|
2
|
|
ASX - By Stock
|
CI1 |
Re:
CI1 General discussion
|
|
Mom88
|
4.6K |
725K |
5 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
4.6K
|
725K
|
5
|
|
ASX - By Stock
|
CI1 |
Re:
CI1 General discussion
|
|
Mom88
|
4.6K |
725K |
3 |
24/07/22 |
24/07/22 |
ASX - By Stock
|
4.6K
|
725K
|
3
|
|
ASX - By Stock
|
AB1 |
Re:
AB1 Share Price update
|
|
Mom88
|
782 |
339K |
6 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
782
|
339K
|
6
|
|
ASX - By Stock
|
CI1 |
Re:
Ann: CI1 - Profit Warning
|
|
Mom88
|
101 |
17K |
2 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
101
|
17K
|
2
|
|